Idiopathic Thrombocytopenic Purpura Took the Life of a Teen, but Her Organs Saved the Lives of Others

Abbey Luffman was a 16-year-old from Owego, New York excited about getting her learner's permit. She was also very generous; she didn't even hesitate to check the box for organ…

Continue Reading Idiopathic Thrombocytopenic Purpura Took the Life of a Teen, but Her Organs Saved the Lives of Others
12-Year-Old with Idiopathic Thrombocytopenic Purpura Creates Nonprofit to Make Transfusions Easier for Kids
source: pixabay.com

12-Year-Old with Idiopathic Thrombocytopenic Purpura Creates Nonprofit to Make Transfusions Easier for Kids

Ella Casano is a 12-year-old living with Idiopathic Thrombocytopenic Purpura (ITP) who had a brilliant idea about how she could help other children living with rare diseases like her own.…

Continue Reading 12-Year-Old with Idiopathic Thrombocytopenic Purpura Creates Nonprofit to Make Transfusions Easier for Kids
Data Shows That Revolade is the Most Effective Second Line Immune Thrombocytopenia Therapy
frolicsomepl / Pixabay

Data Shows That Revolade is the Most Effective Second Line Immune Thrombocytopenia Therapy

According to a story from Market Screener, an analysis of real-world data (data gathered outside of the clinical setting) suggests that the drug eltrombopag, marketed as Revolade, offers substantial advantages…

Continue Reading Data Shows That Revolade is the Most Effective Second Line Immune Thrombocytopenia Therapy